ArticleGlobal health action2013
The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions.
Article in Global health action, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.
- Strengthening research capacity: a systematic review of manuscript writing and publishing interventions for researchers in low-income and middle-income countries.BMJ global health · 2022Pooled it
- Stuck in the middle: a systematic review of authorship in collaborative health research in Africa, 2014-2016.BMJ global health · 2019Pooled it
- From researchBMJ global health · 2026Article
- Research waste before research begins: the problem of research-priority mismatch in low- and middle-income countries.Journal of global health · 2026Article
- Advancing the systematic implementation of patient experience data in healthcare decision-making: multi-stakeholder insights on barriers, opportunities and policy ways forward.Health research policy and systems · 2026Article
- The Health of Nations Fund: Financing global drug development.PLOS global public health · 2026Article
- An international cross-sectional study of dementia researchers' own perspectives on patient and public involvement.Scientific reports · 2025Article
- The persistence of very low correlations between NIH research funding and disease burdens.Public health in practice (Oxford, England) · 2025Article
- Improving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals.Frontiers in health services · 2025Article
- A compound analysis of medical device clinical trials registered in Africa on clinicaltrials.gov.Trials · 2024Review
- Perspectives of old-age and dementia researchers on communication with policymakers and public research funding decision-makers: an international cross-sectional survey.Frontiers in medicine · 2024Article
- Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislation.Frontiers in medicine · 2024Article
- Income inequality and healthcare utilization of the older adults-based on a study in three provinces and six cities in China.Frontiers in public health · 2024Article
- Migration health research in Norway: a scoping review.Scandinavian journal of public health · 2023Article
- Evolution of research funding for neglected tropical diseases in Brazil, 2004-2020.PLoS neglected tropical diseases · 2023Article
- Mitigating the effects of climate change on human health with vaccines and vaccinations.Frontiers in public health · 2023Review
- Management of fracture-related infection in low resource settings: how applicable are the current consensus guidelines?EFORT open reviews · 2022Review
- Ethical considerations in international clinical trial site selection.BMJ global health · 2022Review
- Does Innovation Make Nations More Healthy? Evidence from Developing and Developed Countries.Journal of the knowledge economy · 2022Article
- An analysis of the strategic plan development processes of major public organisations funding health research in nine high-income countries worldwide.Health research policy and systems · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the most pressing global health problems is that there is a mismatch between the health research and development (R&D) that is needed and that which is undertaken. The dependence of health R&D on market incentives in the for-profit private sector and the lack of coordination by public and philanthropic funders on global R&D priorities have resulted in a global health R&D landscape that neglects certain products and populations and is characterised, more generally, by a distribution that is not 'needs-driven'. This article provides an overview of the mismatch, its causes, and solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.